• 1
    Veronesi U, Saccozi R, Del Vecchio M, et al. Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast. N Eng J Med. 1981; 305: 611.
  • 2
    Lagios MD Multicentricity of breast carcinoma demonstrated by routine correlated serial subgross and radiographic examination. Cancer. 1977; 40: 17261734.
  • 3
    Holland R, Veling SH, Mravunac M, Hendriks JH. Histologic multifocality of Tis, T1–2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer. 1985; 56: 979990.
  • 4
    Vaidya JS, Vyas JJ, Chinoy RF, et al. Multicentricity of breast cancer: whole-organ analysis and clinical implications. Br J Cancer. 1996; 74: 820824.
  • 5
    Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002; 347: 12271232.
  • 6
    Fisher B, Anderson S, Bryant J, et al. Twenty year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002; 347: 12331241.
  • 7
    van Dongen J, Voogd AC, Fentiman IS, et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst. 2000; 92: 11431150.
  • 8
    Poggi MM, Danforth DN, Sciuto LC, et al. Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized Trial. Cancer. 2003; 98: 697702.
  • 9
    Blichert-Toft M, Rose C, Andersen JA, et al. Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. Danish Breast Cancer Cooperative Group. J Natl Cancer Inst Monogr. 1992: 1925.
  • 10
    Montgomery DA, Krupa K, Jack WJ, et al. Changing pattern of the detection of locoregional relapse in breast cancer: the Edinburgh experience. Br J Cancer. 2007; 96: 18021807.
  • 11
    Wapnir I, Anderson S, Mamounas E, Geyer C Survival after IBTR in NSABP Node Negative Protocols B-13, B-14, B-19, B-20, and B-23 [abstract]. J Clin Oncol. 2005; 23: 8s. Abstract 517.
  • 12
    Mirza NQ, Vlastos G, Meric F, et al. Predictors of locoregional recurrence among patients with early-stage breast cancer treated with breast-conserving therapy. Ann Surg Oncol. 2002; 9: 256265.
  • 13
    Park CC, Mitsumori M, Nixon A, et al. Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence. J Clin Oncol. 2000; 18: 16681675.
  • 14
    Smitt MC, Nowels KW, Zdeblick MJ, et al. The importance of the lumpectomy surgical margin status in long-term results of breast conservation. Cancer. 1995; 76: 259267.
  • 15
    Peterson ME, Schultz DJ, Reynolds C, Solin LJ. Outcomes in breast cancer patients relative to margin status after treatment with breast-conserving surgery and radiation therapy: the University of Pennsylvania experience. Int J Radiat Oncol Biol Phys. 1999; 43: 10291035.
  • 16
    Saslow D, Boetes C, Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin. 2007; 57: 7589.
  • 17
    Lord SJ, Lei W, Craft P, et al. A systematic review of the effectiveness of magnetic resonance imaging (MRI) as an addition to mammography and ultrasound in screening young women at high risk of breast cancer. Eur J Cancer. 2007; 43: 19051917.
  • 18
    Turnbull LW. Dynamic contrast-enhanced MRI in the diagnosis and management of breast cancer. NMR Biomed. 2009; 22: 2839.
  • 19
    Kopans DB. Magnetic resonance imaging of the breast. In: KopansDB, ed. Breast Imaging, Third Edition. Lippincott Williams Wilkins; 2006: 691728.
  • 20
    Liberman L. Breast MR imaging in assessing extent of disease. Magn Reson Imaging Clin N Am. 2006; 14: 339349.
  • 21
    Morrow M, Freedman G. A clinical oncology perspective on the use of breast MR. Magn Reson Imaging Clin N Am. 2006; 14: 363378.
  • 22
    Schnall M. MR imaging evaluation of cancer extent: Is there clinical relevance. Magn Reson Imaging Clin N Am. 2006; 14: 379381.
  • 23
    Kuhl C, Kuhn W, Braun M, Schild H. Pre-operative staging of breast cancer with breast MRI: one step forward, two steps back. Breast. 2007; (16 suppl 2): S34S44.
  • 24
    Lehman CD, Gatsonis C, Kuhl CK, et al. ACRIN Trial 6667 Investigators Group. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med. 2007; 356: 12951303.
  • 25
    Houssami N, Ciatto S, Macaskill P, et al. Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. J Clin Oncol. 2008; 26: 32483258.
  • 26
    Bleicher RJ, Ciocca RM, Egleston BL, et al. The association of routine pretreatment magnetic resonance imaging with time to surgery, mastectomy rate, and margin status. J Am Coll Surg. 2009 Epub ahead of print June 2009 (doi:10.1016/j.jamcollsurg. 2009.04.010).
  • 27
    Morris AD, Morris RD, Wilson JF, et al. Breast-conserving therapy vs mastectomy in early-stage breast cancer: a meta-analysis of 10-year survival. Cancer J Sci Am. 1997; 3: 612.
  • 28
    Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005; 366: 20872106.
  • 29
    Morrow M, Strom EA, Bassett LW, et al. Standard for breast conservation therapy in the management of invasive breast carcinoma. CA Cancer J Clin. 2002; 52: 277300.
  • 30
    NIH consensus conference. Treatment of early-stage breast cancer. JAMA. 1991; 265: 391395.
  • 31
    Schwartz GF, Veronesi U, Clough KB, et al. Consensus Conference Committee Proceedings of the Consensus Conference on Breast Conservation, April 28 to May 1, 2005, Milan, Italy. Cancer. 2006; 107: 242250.
  • 32
    Mamounas EP. Continuing evolution in breast cancer surgical management. J Clin Oncol. 2005; 23: 16031606.
  • 33
    Newman LA, Kuerer HM. Advances in breast conservation therapy. J Clin Oncol. 2005; 23: 16851697.
  • 34
    Newman LA, Washington TA. New trends in breast conservation therapy. Surg Clin North Am. 2003; 83: 841883.
  • 35
    Singletary SE. Surgical margins in patients with early-stage breast cancer treated with breast conservation therapy. Am J Surg. 2002; 184: 383393.
  • 36
    Kreike B, Hart AA, van de Velde T, et al. Continuing risk of ipsilateral breast relapse after breast-conserving therapy at long-term follow-up. Int J Radiat Oncol Biol Phys. 2008; 71: 10141021.
  • 37
    Harris JR, Morrow M. Treatment of early-stage breast cancer In: HarrisJR, LippmanME, MorrowM, HellmanS, eds. Diseases of the Breast. Philadelphia, Pa: Lippincott Raven; 1996: 487547
  • 38
    Al-Ghazal SK, Fallowfield L, Blamey RW. Comparison of psychological aspects and patient satisfaction following breast conserving surgery, simple mastectomy and breast reconstruction. Eur J Cancer. 2000; 36: 19381943.
  • 39
    Schain WS, d'Angelo TM, Dunn ME, Lichter AS, Pierce LJ. Mastectomy versus conservative surgery and radiation therapy. Psychological consequences. Cancer. 1994; 73: 12211228.
  • 40
    Kiebert GM, de Haes JC, van de Velde CJ. The impact of breast-conserving treatment and mastectomy on the quality of life of early-stage breast cancer patients: a review. J Clin Oncol. 1991; 9: 10591070.
  • 41
    Bilimoria KY, Cambic A, Hansen NM, Bethke KP. Evaluating the impact of preoperative breast magnetic resonance imaging on the surgical management of newly diagnosed breast cancers. Arch Surg. 2007; 142: 441445; discussion 445–447.
  • 42
    Deurloo EE, Peterse JL, Rutgers EJ, et al. Additional breast lesions in patients eligible for breast-conserving therapy by MRI: impact on preoperative management and potential benefit of computerised analysis. Eur J Cancer. 2005; 41: 13931401.
  • 43
    Berg WA, Gutierrez L, NessAiver MS, et al. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology. 2004; 233: 830849.
  • 44
    Bagley FH. The role of magnetic resonance imaging mammography in the surgical management of the index breast cancer. Arch Surg. 2004; 139: 380383; discussion 383.
  • 45
    Liberman L, Morris EA, Dershaw DD, Abramson AF, Tan LK. MR imaging of the ipsilateral breast in women with percutaneously proven breast cancer. AJR Am J Roentgenol. 2003; 180: 901910.
  • 46
    Zhang Y, Fukatsu H, Naganawa S, et al. The role of contrast-enhanced MR mammography for determining candidates for breast conservation surgery. Breast Cancer. 2002; 9: 231239.
  • 47
    Esserman L, Hylton N, Yassa L, et al. Utility of magnetic resonance imaging in the management of breast cancer: evidence for improved preoperative staging. J Clin Oncol. 1999; 17: 110119.
  • 48
    Tan JE, Orel SG, Schnall MD, Schultz DJ, Solin LJ. Role of magnetic resonance imaging and magnetic resonance imaging-guided surgery in the evaluation of patients with early-stage breast cancer for breast conservation treatment. Am J Clin Oncol. 1999; 22: 414418.
  • 49
    Hollingsworth AB, Stough RG. Preoperative breast MRI for locoregional staging. J Okla State Med Assoc. 2006; 99: 505515.
  • 50
    Schelfout K, Van Goethem M, Kersschot E, et al. Contrast-enhanced MR imaging of breast lesions and effect on treatment. Eur J Surg Oncol. 2004; 30: 501507.
  • 51
    Bedrosian I, Mick R, Orel SG, et al. Changes in the surgical management of patients with breast carcinoma based on preoperative magnetic resonance imaging. Cancer. 2003; 98: 468473.
  • 52
    Hlawatsch A, Teifke A, Schmidt M, Thelen M. Preoperative assessment of breast cancer: sonography versus MR imaging. AJR Am J Roentgenol. 2002; 179: 14931501.
  • 53
    Fischer U, Kopka L, Grabbe E. Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. Radiology. 1999; 213: 881888.
  • 54
    Orel SG, Schnall MD, Powell CM, et al. Staging of suspected breast cancer: effect of MR imaging and MR-guided biopsy. Radiology. 1995; 196: 115122.
  • 55
    Sardanelli F, Giuseppetti GM, Panizza P, et al. Italian Trial for Breast MR in Multifocal/Multicentric Cancer. Sensitivity of MRI versus mammography for detecting foci of multifocal, multicentric breast cancer in fatty and dense breasts using the whole-breast pathologic examination as a gold standard. AJR Am J Roentgen. 2004; 183: 11491157.
  • 56
    Boetes C, Mus RD, Holland R, et al. Breast tumors: comparative accuracy of MR imaging relative to mammography and US for demonstrating extent. Radiology. 1995; 197: 743747.
  • 57
    Schnall MD, Blume J, Bluemke DA, et al. MRI detection of distinct incidental cancer in women with primary breast cancer studied in IBMC 6883. J Surg Oncol. 2005; 92: 3238.
  • 58
    Drew PJ, Chatterjee S, Turnbull LW, et al. Dynamic contrast enhanced magnetic resonance imaging of the breast is superior to triple assessment for the pre-operative detection of multifocal breast cancer. Ann Surg Oncol. 1999; 6: 599603.
  • 59
    Mumtaz H, Hall-Craggs MA, Davidson T, et al. Staging of symptomatic primary breast cancer with MR imaging. AJR Am J Roentgenol. 1997; 169: 417424.
  • 60
    Godinez J, Gombos EC, Chikarmane SA, Griffin GK, Birdwell RL. Breast MRI in the evaluation of eligibility for accelerated partial breast irradiation. AJR Am J Roentgenol. 2008; 191: 272277.
  • 61
    Al-Hallaq HA, Mell LK, Bradley JA, et al. Magnetic resonance imaging identifies multifocal and multicentric disease in breast cancer patients who are eligible for partial breast irradiation. Cancer. 2008; 113: 24082414.
  • 62
    Warren R, Ciatto S, Macaskill P, Black R, Houssami N. Technical aspects of breast MRI: do they affect outcomes? Eur Radiol. 2009; 19: 16291638.
  • 63
    Turnbull L. Magnetic resonance imaging in breast cancer: results of the COMICE trial. Breast Cancer Res. 2008; 10(suppl 3): P10.
  • 64
    Pengel KE, Loo CE, Teertstra HJ, et al. The impact of preoperative MRI on breast-conserving surgery of invasive cancer: a comparative cohort study. Breast Cancer Res Treat. 2008 Sep 21 [Epub ahead of print].
  • 65
    Fischer U, Zachariae O, Baum F, et al. The influence of preoperative MRI of the breasts on recurrence rate in patients with breast cancer. Eur Radiol. 2004; 14: 17251731.
  • 66
    Arriagada R, Le MG, Guinebretiere JM, et al. Late local recurrences in a randomised trial comparing conservative treatment with total mastectomy in early breast cancer patients. Ann Oncol. 2003; 14: 16171622.
  • 67
    Offersen BV, Overgaard M, Kroman N, Overgaard J. Accelerated partial breast irradiation as part of breast conserving therapy of early breast carcinoma: a systematic review. Radiother Oncol. 2009; 90: 113.
  • 68
    Lee SG, Orel SG, Woo IJ, et al. MR imaging screening of the contralateral breast in patients with newly diagnosed breast cancer: preliminary results. Radiology. 2003; 226: 773778.
  • 69
    Liberman L, Morris EA, Kim CM, et al. MR imaging findings in the contralateral breast of women with recently diagnosed breast cancer. AJR. Am J Roentgenol. 2003; 180: 333341.
  • 70
    Pediconi F, Catalano C, Roselli A, et al. Contrast-enhanced MR mammography for evaluation of the contralateral breast in patients with diagnosed unilateral breast cancer or high-risk lesions. Radiology. 2007; 243: 670680.
  • 71
    Brennan M, Houssami N, Lord SJ, et al. MRI screening of the contralateral breast in women with newly diagnosed breast cancer: Systematic review and meta-analysis of incremental cancer detection and impact on surgical management. J Clin Oncol. 2009 (In press).
  • 72
    Schaapveld M, Visser O, Louwman WJ, et al. The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: a population based study in the Netherlands. Breast Cancer Res Treat. 2008; 110: 189197.
  • 73
    Gao X, Fisher SG, Emami B. Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study. Int J Radiat Oncol Biol Phys. 2003; 56: 10381045.
  • 74
    Arimidex, Tamoxifen, Alone or in Combination (ATAC) Trialists' Group, Forbes JF, Cuzick J, Buzdar A, Howell A, Tobias JS, Baum M. Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial. Lancet Oncology. 2008; 9: 4553.
  • 75
    Kramer BS, Croswell JM. Cancer screening: the clash of science and intuition. Annu Rev Med. 2009; 60: 125137.
  • 76
    Lord SJ, Irwig L, Simes RJ. When is measuring sensitivity and specificity sufficient to evaluate a diagnostic test, and when do we need randomized trials. Ann Intern Med. 2006; 144: 850855.
  • 77
    Hayes DF, Bast RC, Desch CE, et al. Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markers. J Natl Cancer Inst. 1996; 88: 14561466.
  • 78
    Lijmer JG, Bossuyt PM. Various randomized designs can be used to evaluate medical tests. J Clin Epidemiol. 2009; 62: 364373.
  • 79
    Houssami N, Cuzick J, Dixon JM. The prevention, detection and management of breast cancer. Med J Aust. 2006; 184: 230234.